Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 1
1997 1
1998 1
1999 2
2000 4
2001 2
2002 7
2003 14
2004 10
2005 30
2006 24
2007 24
2008 31
2009 41
2010 39
2011 41
2012 36
2013 56
2014 57
2015 60
2016 46
2017 47
2018 64
2019 61
2020 59
2021 72
2022 59
2023 57
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

849 results

Results by year

Filters applied: . Clear all
Page 1
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial.
Bauer S, Jones RL, Blay JY, Gelderblom H, George S, Schöffski P, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Su Y, Meade J, Wang T, Sherman ML, Ruiz-Soto R, Heinrich MC. Bauer S, et al. J Clin Oncol. 2022 Dec 1;40(34):3918-3928. doi: 10.1200/JCO.22.00294. Epub 2022 Aug 10. J Clin Oncol. 2022. PMID: 35947817 Free PMC article. Clinical Trial.
PURPOSE: Sunitinib, a multitargeted tyrosine kinase inhibitor (TKI), is approved for advanced gastrointestinal stromal tumor (GIST) after imatinib failure. Ripretinib is a switch-control TKI approved for advanced GIST after prior treatment with three or more …
PURPOSE: Sunitinib, a multitargeted tyrosine kinase inhibitor (TKI), is approved for advanced gastrointestinal stromal tumo …
The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior.
Tariq MU, Din NU, Abdul-Ghafar J, Park YK. Tariq MU, et al. Diagn Pathol. 2021 Apr 20;16(1):32. doi: 10.1186/s13000-021-01095-2. Diagn Pathol. 2021. PMID: 33879215 Free PMC article. Review.
Owing to diverse histological features and involvement of diverse anatomic locations, SFT can mimic other soft tissue neoplasms of different lineages including schwannoma, spindle cell lipoma, dermatofibrosarcoma protuberans, liposarcoma, gastrointestinal stromal …
Owing to diverse histological features and involvement of diverse anatomic locations, SFT can mimic other soft tissue neoplasms of different …
Combination of arginine, glutamine, and omega-3 fatty acid supplements for perioperative enteral nutrition in surgical patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST): A prospective, randomized, double-blind study.
Ma C, Tsai H, Su W, Sun L, Shih Y, Wang J. Ma C, et al. J Postgrad Med. 2018 Jul-Sep;64(3):155-163. doi: 10.4103/jpgm.JPGM_693_17. J Postgrad Med. 2018. PMID: 29848836 Free PMC article. Clinical Trial.
In this study, perioperative EN enriched with immune-modulating nutrients such as arginine, glutamine, and omega-3 fatty acids was evaluated for its anti-inflammatory efficacy in patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST) re …
In this study, perioperative EN enriched with immune-modulating nutrients such as arginine, glutamine, and omega-3 fatty acids was evaluated …
Extra-Gastrointestinal Stromal Tumor of Prostate.
Etit D, Kar H, Ekinci N, Yenipazar AE, Çakalağaoğlu F. Etit D, et al. Balkan Med J. 2017 Apr 5;34(2):168-171. doi: 10.4274/balkanmedj.2015.1331. Balkan Med J. 2017. PMID: 28418346 Free PMC article.
BACKGROUND: Extra-gastrointestinal stromal tumor is defined as a mesenchymal neoplasm arising from soft tissues outside the gastrointestinal tract. Prostatic extra-gastrointestinal stromal tumor has rarely been noted. CASE REPORT: A 56 ye …
BACKGROUND: Extra-gastrointestinal stromal tumor is defined as a mesenchymal neoplasm arising from soft tissues outside …
KIT gene mutations in gastrointestinal stromal tumor.
Kang W, Zhu C, Yu J, Ye X, Ma Z. Kang W, et al. Front Biosci (Landmark Ed). 2015 Jun 1;20(6):919-26. doi: 10.2741/4346. Front Biosci (Landmark Ed). 2015. PMID: 25961532 Free article. Review.
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. ...KIT gene mutation is a feature of GIST, in addition to PDGFRA gene mutation. KIT gene mutations have been observed to be involved in the develo …
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. ...KIT gene m …
Clinicopathological and therapeutic analysis of PDGFRA mutated gastrointestinal stromal tumor.
Huang W, Yuan W, Ren L, Liang H, Du X, Sun X, Fang Y, Gao X, Fu M, Sun Y, Shen K, Hou Y. Huang W, et al. Pathol Res Pract. 2022 Nov;239:154138. doi: 10.1016/j.prp.2022.154138. Epub 2022 Sep 19. Pathol Res Pract. 2022. PMID: 36183438
BACKGROUND: Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) mutation has causes a rare subgroup of gastrointestinal stromal tumor (GIST) and not too much attention has been paid on it until the appearance of Avapritinib. ...During a median followup of …
BACKGROUND: Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) mutation has causes a rare subgroup of gastrointestinal stromal …
Molecular subtypes of gastrointestinal stromal tumor requiring specific treatments.
Pogorzelski M, Falkenhorst J, Bauer S. Pogorzelski M, et al. Curr Opin Oncol. 2016 Jul;28(4):331-7. doi: 10.1097/CCO.0000000000000303. Curr Opin Oncol. 2016. PMID: 27163723 Review.
PURPOSE OF REVIEW: This article reviews and discusses the current literature on how molecular subtyping of gastrointestinal stromal tumor (GIST) impacts decision-making in clinical practice. ...Subgroup analyses of randomized trials provide first evidence on …
PURPOSE OF REVIEW: This article reviews and discusses the current literature on how molecular subtyping of gastrointestinal stroma …
MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor.
Hemming ML, Benson MR, Loycano MA, Anderson JA, Andersen JL, Taddei ML, Krivtsov AV, Aubrey BJ, Cutler JA, Hatton C, Sicinska E, Armstrong SA. Hemming ML, et al. Cancer Discov. 2022 Jul 6;12(7):1804-1823. doi: 10.1158/2159-8290.CD-21-0646. Cancer Discov. 2022. PMID: 35499757 Free PMC article.
Gastrointestinal stromal tumor (GIST) is commonly characterized by activating mutations in the receptor tyrosine kinase KIT. ...MOZ and Menin inhibition caused significant reductions in tumor burden in vivo, with superior effects observed with combined …
Gastrointestinal stromal tumor (GIST) is commonly characterized by activating mutations in the receptor tyrosine kinase …
Response assessment in gastrointestinal stromal tumor.
Desai J. Desai J. Int J Cancer. 2011 Mar 15;128(6):1251-8. doi: 10.1002/ijc.25729. Epub 2011 Jan 7. Int J Cancer. 2011. PMID: 20957633 Free article. Review.
Imatinib is standard first-line treatment for patients with advanced gastrointestinal stromal tumor (GIST). Initial responses are not always accompanied by reductions in tumor size; consequently, other parameters should be considered in response assessments. …
Imatinib is standard first-line treatment for patients with advanced gastrointestinal stromal tumor (GIST). Initial res …
Impact of Tumor Size and Management on Survival in Small Gastric Gastrointestinal Stromal Tumors.
Rhodin KE, DeLaura IF, Horne E, Bartholomew A, Howell TC, Kanu E, Masoud S, Lidsky ME, Nussbaum DP, Blazer DG 3rd. Rhodin KE, et al. J Gastrointest Surg. 2023 Oct;27(10):2076-2084. doi: 10.1007/s11605-023-05779-6. Epub 2023 Jul 11. J Gastrointest Surg. 2023. PMID: 37433950

Herein, we aimed to assess survival among patients with gastric GISTs undergoing observation versus surgical resection, stratified by tumor size. METHODS: The National Cancer Database (NCDB) was queried for gastric GISTs < 2 cm diagnosed from 2010-2017. Patients were st

…
Herein, we aimed to assess survival among patients with gastric GISTs undergoing observation versus surgical resection, stratified by …
849 results